Deutsche Bank Ag\ Idera Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.06 - $2.15 $15,320 - $31,073	-14,453 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.45 - $2.79 $20,956 - $40,323	14,453 New	14,453 $26,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $3.31 $10,220 - $15,957	-4,821 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.37 - $3.97 $253,672 - $424,928	-107,035 Reduced 95.69%	4,821 $12,000
Q1 2019 May 15, 2019	BUY	$2.33 - $3.79 $131,197 - $213,407	56,308 Added 101.37%	111,856 $283,000
Q4 2018 Feb 14, 2019	BUY	$2.77 - $9.38 $34,023 - $115,214	12,283 Added 28.39%	55,548 $153,000
Q3 2018 Dec 21, 2021	BUY	$5.53 - $11.36 $27,777 - $57,061	5,023 Added 13.13%	43,265 $385,000
Q3 2018 Nov 14, 2018	BUY	$5.53 - $11.36 $211,478 - $434,429	38,242 New	38,242 $340,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.